Cargando…

Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth

High-mobility group box 1 (HMGB1) has been reported as a damage-associated molecular pattern (DAMP) molecule that is released from damaged or dead cells and induces inflammation and subsequent innate immunity. However, the role of HMGB1 in the anti-tumor immunity is unclear since inflammation in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokomizo, Kanako, Waki, Kayoko, Ozawa, Miyako, Yamamoto, Keiko, Ogasawara, Sachiko, Yano, Hirohisa, Yamada, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840913/ https://www.ncbi.nlm.nih.gov/pubmed/35150340 http://dx.doi.org/10.1007/s12032-022-01659-2

Ejemplares similares

Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen‐specific T cells
por: Waki, Kayoko, et al.
Publicado: (2022)

Blockade of high mobility group box 1 augments antitumor T‐cell response induced by peptide vaccination as a co‐adjuvant
por: Waki, Kayoko, et al.
Publicado: (2016)

Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
por: Waki, Kayoko, et al.
Publicado: (2020)

Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer
por: Waki, Kayoko, et al.
Publicado: (2021)

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer
por: Waki, Kayoko, et al.
Publicado: (2017)

Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line
por: Ogasawara, Sachiko, et al.
Publicado: (2017)

Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo
por: KUSANO, HIRONORI, et al.
Publicado: (2013)

CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients
por: Waki, Kayoko, et al.
Publicado: (2020)

Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression
por: Sasahira, Tomonori, et al.
Publicado: (2016)

Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line
por: Ueda, Kosuke, et al.
Publicado: (2013)

KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells
por: Okamoto, Kengo, et al.
Publicado: (2019)

Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine
por: Koga, Noriko, et al.
Publicado: (2017)

CD44v3(+)/CD24(−) cells possess cancer stem cell-like properties in human oral squamous cell carcinoma
por: TODOROKI, KEITA, et al.
Publicado: (2015)

Expression and role of regulator of G‐protein signaling 5 in squamous cell carcinoma of the tongue
por: Abe, Yushi, et al.
Publicado: (2019)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo
por: Kusano, Hironori, et al.
Publicado: (2013)

Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility
por: Shirouzu, Shinichiro, et al.
Publicado: (2022)

The effectiveness of lamotrigine for persistent depressive disorder: A case report
por: Matsuzaka, Yusuke, et al.
Publicado: (2022)

Correction: Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility
por: Shirouzu, Shinichiro, et al.
Publicado: (2023)

Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma
por: Sumi, Akiko, et al.
Publicado: (2015)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
por: Kawano, Kouichiro, et al.
Publicado: (2015)

Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages
por: Huber, Roman, et al.
Publicado: (2016)

External Ear Melanoma Treated with Auricular Reconstruction Using Four Different Tissues in a 16-Year-Old Patient
por: Takasu, Hiroyuki, et al.
Publicado: (2023)

Postoperative changes in high mobility group box 1 levels after colorectal cancer surgery
por: Satoh, Masaaki, et al.
Publicado: (2016)

Specific detection of high mobility group box 1 degradation product with a novel ELISA
por: Totoki, Takaaki, et al.
Publicado: (2021)

Macrophages and Cell-Cell Spread of HIV-1
por: Waki, Kayoko, et al.
Publicado: (2010)

Single-Nucleotide Polymorphism on Spermatogenesis Associated 16 Gene-Coding Region Affecting Bovine Leukemia Virus Proviral Load
por: Mekata, Hirohisa, et al.
Publicado: (2022)

Legionella pneumophila induces cathepsin B-dependent necrotic cell death with releasing high mobility group box1 in macrophages
por: Morinaga, Yoshitomo, et al.
Publicado: (2010)

PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer
por: Waki, Kayoko, et al.
Publicado: (2014)

Significance of a psychiatry rotation for subjective achievement of competencies related to psychiatry in the Japanese postgraduate residency system
por: Matsuzaka, Yusuke, et al.
Publicado: (2021)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1
por: Liu, Hao, et al.
Publicado: (2016)

Endogenous CCL21-Ser deficiency reduces B16–F10 melanoma growth by enhanced antitumor immunity
por: Fujie, Ryonosuke, et al.
Publicado: (2023)

Inducible knockout of Clec16a in mice results in sensory neurodegeneration
por: Hain, Heather S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hefcol746rn18lhljj7vhk177k